Billions of dollars have poured into the so-called "liquid biopsy" business — much of it to companies in the Bay Area — aimed at detecting cancer early, in some cases before symptoms even appear.
Illumina sues Guardant Health, founders in showdown of early cancer detection companies
Billions of dollars have poured into the so-called "liquid biopsy" business — much of it to companies in the Bay Area — aimed at detecting cancer early, in some cases before symptoms even appear.
